ACTIVE_NOT_RECRUITING

COPD Care Pathway Among Patients With Cancer

Conditions

Chronic Obstructive Pulmonary Disease Lung Cancer Head and Neck Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.

Official Title

User-Centered Design of a COPD Care Pathway for Patients With Cancer

Quick Facts

Study Start:2025-02-27

Study Completion:2026-03

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05984680

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria: 1. patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or 2. provider who currently works at least part-time in a medical oncology clinic or 3. provider who works at least part-time to care for patients with known or suspected COPD. * Ability to understand and agree to participate on the study as described by the study information sheet. * Capability of speaking or reading English.	Pregnancy or breastfeeding Severe psychiatric disorders Active substance abuse Unstable medical conditions Inability to comply with study requirements

Inclusion Criteria

Exclusion Criteria

* The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
1. patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
2. provider who currently works at least part-time in a medical oncology clinic or
3. provider who works at least part-time to care for patients with known or suspected COPD.
* Ability to understand and agree to participate on the study as described by the study information sheet.
* Capability of speaking or reading English.

Pregnancy or breastfeeding
Severe psychiatric disorders
Active substance abuse
Unstable medical conditions
Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Thomas Lycan, MD

PRINCIPAL_INVESTIGATOR

Wake Forest Baptist Comprehensive Cancer Center

Study Locations (Sites)

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157

United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

Thomas Lycan, MD, PRINCIPAL_INVESTIGATOR, Wake Forest Baptist Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-27

Study Completion Date2026-03

Study Record Updates

Study Start Date2025-02-27

Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

Chronic Obstructive Pulmonary Disease
Lung Cancer
Head and Neck Cancer